The Role of Inflammation in Cardiovascular Diseases
Inflammation plays a pivotal role in the development and progression of cardiovascular diseases. Chronic inflammation contributes to the initiation and progression of atherosclerosis, where inflammatory cells infiltrate the arterial walls, leading to plaque formation and arterial narrowing. Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), exacerbate endothelial dysfunction and promote plaque instability, increasing the risk of cardiovascular events like myocardial infarction and stroke. Systemic inflammation is also linked to conditions such as heart failure, where it exacerbates myocardial injury and remodeling. Recent research has identified inflammatory biomarkers like high-sensitivity C-reactive protein (hs-CRP) as useful tools in assessing cardiovascular risk and guiding therapy. Targeting inflammation with new therapies, such as anti-inflammatory drugs and monoclonal antibodies, holds promise for mitigating disease progression and improving cardiovascular outcomes. Understanding inflammation's role helps in developing strategies to prevent and manage cardiovascular diseases more effectively.